While Excel Life Sciences has developed one of the largest networks of investigators and investigative sites, it’s important to understand that we select and accept only the most qualified people and organizations into that network. These investigators and sites undergo a rigorous review process that includes examination of over 150 different data points and each is expected to exceed in three critical areas:

• Quality
• Ethics
• Performance

On an ongoing basis, the ELS study coordinators and project management team visit, review and evaluate new clinicians and sites to be added to the network. This due diligence process does not end once a site has been accepted into the network, but instead is ongoing with reevaluation taking place annually and based on dynamic performance records. Below are some facts about the ELS network for your review. ELS helps excellent physicians become successful investigators.

• Over 1000 research centers and hospitals nationwide
• Nearly 1350 investigators
• Over 150 data points are collected and evaluated for each site
• ELS investigative sites are located in more than 25 cities across India
• Sites specializing in more than 14 therapeutic areas
• Each site is supported by a full-time ELS study coordinator (when involved in an ELS study)
• ELS clinical operations team has managed investigative sites that have Undergone successful US FDA inspections